Connect with us

Health & Fitness

Tofacitinib Retreatment Effective for Ulcerative Colitis

Clinical response can be recaptured in patients who have had to interrupt treatment with tofacitinib, a JAK inhibitor, for up to 2 months, an analysis of data from the OCTAVE extension trial shows. Medscape Medical News

Published

on

Tofacitinib Retreatment Effective for Ulcerative Colitis

Clinical response can be recaptured in patients who have had to interrupt treatment with tofacitinib, a JAK inhibitor, for up to 2 months, an analysis of data from the OCTAVE extension trial shows. Medscape Medical News
Read More